Vitamin D in Orthopädie und Unfallchirurgie

Zusammenfassung

Ziel der vorliegenden Arbeit ist es, das Verständnis der Physiologie, des Stoffwechsels und der biologischen Funktionen von Vitamin D zu vertiefen sowie Hinweise zur Identifizierung von Risikopatienten und schließlich zur Behandlung eines Vitamin-D-Mangels zu geben. Die Ausführungen stützen sich im Wesentlichen auf einen Artikel von Holick aus dem Jahr 2024 [1] sowie die von Holick et al. 2011 und von Demay et al. 2024 publizierten Leitlinien der Endocrine Society [2], [3], wobei die jüngste Leitlinie im Gegensatz zu 2011 auf eine Risikobewertung von Vitamin-D-assoziierten Erkrankungen bei Individuen mit bisher nicht etablierten Indikationen für eine Vitamin-D-Supplementation bzw. -Messung abzielt.

Schlüsselwörter

Vitamin D - Vitamin-D-Mangel - Vitamin-D-assoziierte Erkrankungen - Supplementierung - Osteoporose - Frakturen

Publication History

Article published online:
26 February 2025

• Literatur

• 1 Holick MF. Vitamin D and bone health: What vitamin D can and cannot do. Adv Food Nutr Res 2024; 109: 43-66
• 2 Holick MF, Binkley NC, Bischoff-Ferrari HA. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930
• 3 Demay MB, Pittas AG, Bikle DD. et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2024; 109: 1907-1947
• 4 Wacker M, Holick MF. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol 2013; 5: 51-108
• 5 Holick MF. The One-Hundred-Year Anniversary of the Discovery of the Sunshine Vitamin D₃: Historical, Personal Experience and Evidence-Based Perspectives. Nutrients 2023; 15
• 6 Hernigou P, Sitbon J, Dubory A. et al. Vitamin D history part III: the “modern times” – new questions for orthopaedic practice: deficiency, cell therapy, osteomalacia, fractures, supplementation, infections. Int Orthop 2019; 43: 1755-1771
• 7 Mellanby E, Cantag MD. An experimental investigation on rickets. Lancet 1919; 196: 407-412
• 8 Maier GS, Maus U, Lazovic D. et al. Vitamin D in Orthopädie und Unfallchirurgie. Osteologie 2018; 27: 123-128
• 9 Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281
• 10 Kazemian E, Pourali A, Sedaghat F. et al. Effect of supplemental vitamin D₃ on bone mineral density: a systematic review and meta-analysis. Nutr Rev 2023; 81: 511-530
• 11 Charoenngam N, Shirvani A, Holick MF. Vitamin D for skeletal and non-skeletal health: What we should know. J Clin Orthop Trauma 2019; 10: 1082-1093
• 12 Nakamichi Y, Takahashi N, Suda T. et al. Osteoclastogenesis and vitamin D. In: Feldman and Pike’ s Vitamin D. London/UK, San Diego/CA/US, Cambridge/MA/US, Oxford/UK: Academic Press, imprint of Elsevier; 2024: 395-408
• 13 Dzik KP, Kaczor JJ. Mechanisms of vitamin D on skeletal muscle function: oxidative stress, energy metabolism and anabolic state. Eur J Appl Physiol 2019; 119: 825-839
• 14 Tomlinson PB, Joseph C, Angioi M. Effects of vitamin D supplementation on upper and lower body muscle strength levels in healthy individuals. A systematic review with meta-analysis. J Sci Med Sport 2015; 18: 575-580
• 15 Ceglia L, Niramitmahapanya S, Da Silva Morais M. et al. A randomized study on the effect of vitamin D₃ supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metab 2013; 98: E1927-1935
• 16 Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995; 61: 638S-645S
• 17 Haddad JG, Matsuoka LY, Hollis BW. et al. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993; 91: 2552-2555
• 18 Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080S-1086S
• 19 Christakos S, Dhawan P, Liu Y. et al. New insights into the mechanisms of vitamin D action. J Cell Biochem 2003; 88: 695-705
• 20 Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004; 80: 1706S-1709S
• 21 Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005; 289: F8-28
• 22 Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-478
• 23 Bouillon R, Bischoff-Ferrari H, Willett W. Vitamin D and health: perspectives from mice and man. J Bone Miner Res 2008; 23: 974-979
• 24 Liu PT, Stenger S, Li H. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773
• 25 Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662-687
• 26 Moan J, Porojnicu AC, Dahlback A. et al. Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc Natl Acad Sci U S A 2008; 105: 668-673
• 27 Tebben PJ, Milliner DS, Horst RL. et al. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J Clin Endocrinol Metab 2012; 97: E423-E427
• 28 Schlingmann KP, Kaufmann M, Weber S. et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011; 365: 410-421
• 29 Jacobs TP, Kaufman M, Jones G. et al. A lifetime of hypercalcemia and hypercalciuria, finally explained. J Clin Endocrinol Metab 2014; 99: 708-712
• 30 Clemens TL, Adams JS, Henderson SL. et al. Increased skin pigment reduces the capacity of skin to synthesise vitamin D₃ . Lancet 1982; 1: 74-76
• 31 Hintzpeter B, Scheidt-Nave C, Müller MJ. et al. Higher prevalence of vitamin D deficiency is associated with immigrant background among children and adolescents in Germany. J Nutr 2008; 138: 1482-1490
• 32 Matsuoka LY, Ide L, Wortsman J. et al. Sunscreens suppress cutaneous vitamin D₃ synthesis. J Clin Endocrinol Metab 1987; 64: 1165-1168
• 33 Wallace AM, Gibson S, de La Hunty A. et al. Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids 2010; 75: 477-488
• 34 Heaney RP, Dowell MS, Hale CA. et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003; 22: 142-146
• 35 Cavalier E, Rozet E, Gadisseur R. et al. Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporos Int 2010; 21: 1047-1051
• 36 Dachverband Osteologie. Prophylaxe, Diagnostik und Therapie der Prophylaxe, Diagnostik und Therapie der OSTEOPOROSE bei postmenopausalen Frauen und bei Männern ab dem 50. Lebensjahr. Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e. V. 2023. Im Internet: Accessed November 04, 2024 at: https://leitlinien.dv-osteologie.org/wp-content/uploads/2024/02/DVO-Leitlinie-zur-Diagnostik-und-Therapie-der-Osteoporose-Version-2.1.-2023–002.pdf
• 37 Maier GS, Seeger JB, Horas K. et al. The prevalence of vitamin D deficiency in patients with vertebral fragility fractures. Bone Joint J 2015; 97-B: 89-93
• 38 Cummings SR, Browner WS, Bauer D. et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1998; 339: 733-738
• 39 Roux C, Briot K, Horlait S. et al. Assessment of non-vertebral fracture risk in postmenopausal women. Ann Rheum Dis 2007; 66: 931-935
• 40 Snijder MB, van Schoor NM, Pluijm SMF. et al. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 2006; 91: 2980-2985
• 41 Flicker L, Mead K, MacInnis RJ. et al. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 2003; 51: 1533-1538
• 42 Sambrook PN, Chen JS, March LM. et al. Serum parathyroid hormone predicts time to fall independent of vitamin D status in a frail elderly population. J Clin Endocrinol Metab 2004; 89: 1572-1576
• 43 Garnero P, Munoz F, Sornay-Rendu E. et al. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone 2007; 40: 716-722
• 44 Powe CE, Ricciardi C, Berg AH. et al. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 2011; 26: 1609-1616
• 45 Cauley JA, Parimi N, Ensrud KE. et al. Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. J Bone Miner Res 2010; 25: 545-553
• 46 Cauley JA, Lacroix AZ, Wu L. et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008; 149: 242-250
• 47 Melhus H, Snellman G, Gedeborg R. et al. Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. J Clin Endocrinol Metab 2010; 95: 2637-2645
• 48 Koning Lde, Henne D, Hemmelgarn BR. et al. Non-linear relationship between serum 25-hydroxyvitamin D concentration and subsequent hip fracture. Osteoporos Int 2013; 24: 2061-2065
• 49 Glendenning P, Zhu K, Inderjeeth C. et al. Effects of three-monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility, and muscle strength in older postmenopausal women: a randomized controlled trial. J Bone Miner Res 2012; 27: 170-176
• 50 Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ. et al. Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline: A Randomized Clinical Trial. JAMA Intern Med 2016; 176: 175-183
• 51 Sanders KM, Stuart AL, Williamson EJ. et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815-1822
• 52 Bacon CJ, Gamble GD, Horne AM. et al. High-dose oral vitamin D₃ supplementation in the elderly. Osteoporos Int 2009; 20: 1407-1415
• 53 Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842-856
• 54 El-Hajj Fuleihan G, Nabulsi M, Tamim H. et al. Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. J Clin Endocrinol Metab 2006; 91: 405-412
• 55 Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008; 88: 582S-586S
• 56 Kearns MD, Alvarez JA, Seidel N. et al. Impact of vitamin D on infectious disease. Am J Med Sci 2015; 349: 245-262
• 57 Ginde AA, Mansbach JM, Camargo CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169: 384-390
• 58 Ginde AA, Camargo CA, Shapiro NI. Vitamin D insufficiency and sepsis severity in emergency department patients with suspected infection. Acad Emerg Med 2011; 18: 551-554
• 59 Mercy DJ, Girigoswami A, Girigoswami K. Relationship between urinary tract infections and serum vitamin D level in adults and children- a literature review. Mol Biol Rep 2024; 51: 955
• 60 Tiwari S, Pratyush DD, Gupta B. et al. Prevalence and severity of vitamin D deficiency in patients with diabetic foot infection. Br J Nutr 2013; 109: 99-102
• 61 Maier GS, Horas K, Seeger JB. et al. Is there an association between periprosthetic joint infection and low vitamin D levels?. Int Orthop 2014; 38: 1499-1504
• 62 Horas K, Hoxha M, Heinz T. et al. Prevalence and Risk Factors of Vitamin D Deficiency in Patients Scheduled to Undergo Revision Arthroplasty of the Hip, Knee and Shoulder-Data from a Single-Centre Analysis. Nutrients 2024; 16
• 63 Zhang X, Wu J, Dong H. et al. The impact of supplementing vitamin D through different methods on the prognosis of COVID-19 patients: a systematic review and meta-analysis. Front Nutr 2024; 11: 1441847
• 64 Ghoreshi Z-A-S, Charostad J, Arefinia N. et al. Effect of vitamin D supplementation on clinical outcomes in adult patients with COVID-19: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Pharmacol Res Perspect 2024; 12: e70013
• 65 Holick MF. Evidence-based D-bate on health benefits of vitamin D revisited. Dermatoendocrinol 2012; 4: 183-190
• 66 Bolland MJ, Grey A, Avenell A. et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 2011; 342: d2040
• 67 Rosen CJ, Adams JS, Bikle DD. et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 2012; 33: 456-492
• 68 Ekwaru JP, Zwicker JD, Holick MF. et al. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One 2014; 9: e111265
• 69 Zhang J-J, Yu H-C, Geng T-T. et al. Serum 25-hydroxyvitamin D concentrations, vitamin D receptor polymorphisms, and risk of infections among individuals with type 2 diabetes: a prospective cohort study. Am J Clin Nutr 2024; 120: 398-406
• 70 Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D₃ (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003; 326: 469
• 71 Wactawski-Wende J, Kotchen JM, Anderson GL. et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354: 684-696
• 72 Dankers W, Colin EM, van Hamburg JP. et al. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front Immunol 2016; 7: 697
• 73 Mazur A, Frączek P, Tabarkiewicz J. Vitamin D as a Nutri-Epigenetic Factor in Autoimmunity-A Review of Current Research and Reports on Vitamin D Deficiency in Autoimmune Diseases. Nutrients 2022; 14
• 74 Heaney RP, Davies KM, Chen TC. et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77: 204-210
• 75 LeBlanc ES, Perrin N, Johnson JD. et al. Over-the-counter and compounded vitamin D: is potency what we expect?. JAMA Intern Med 2013; 173: 585-586
• 76 Burckhardt P. Ernährung und Knochengesundheit. Osteologie 2008; 17: 35